Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Choose from a selection of modern and traditional designs in single or twin packs to support type 1 diabetes research this Christmas. Shop online and get fast delivery.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This legendary half marathon sees 60,000 runners take to the streets of Newcastle, crossing the iconic Tyne Bridge and finishing in sunny South Shields.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > Knowledge & support > Resource hub > Diversity in research participants: “It’s time to turn policy into action”
Experts from leading research organisations, including Medical Research Council and American Diabetes Association, are calling for action to increase the diversity of people taking part in research.
Diversity refers to having a variety of differences and unique qualities among individuals. The characteristics of the people taking part in a research study should reflect the community the research is for. If this doesn’t happen, some groups of people are underrepresented, meaning the findings of the research may not be applicable to them. Researchers should actively strive to include a variety of individuals in their studies to promote fairness, inclusivity, and the advancement of science.
Having diversity in research participants is essential for addressing the unique needs and experiences of different populations. Data from National Institute for Health and Care Research has found that UK areas with the highest prevalence of disease also have the fewest residents taking part in research. So, new drugs are often tested on healthier people who may not respond in the same way. Including people from a range of demographics in research produces more meaningful and applicable results and ensures ethical research practices with less bias.
American Diabetes Association President of Health Care & Education, Janet Brown-Friday, has called for action to ensure clinical trials are representative of the population the drugs are being tested for. She has suggested making funding for clinical trials dependent on researchers designing their studies to actively recruit and include people from minority groups.
In fact, Medical Research Council (MRC), a major funder of biomedical research, has done just that to become the first UK research funder to require their researchers to make diversity an essential part of their research. In June 2023, MRC announced that a requirement of receiving their research funding is to consider whether features such as sex, gender, age, ethnicity and socio-economic status are relevant to the studies they are running.
Find out more about MRC’s policy on diversity.
According to research by NHS England, language barriers, accessibility and mistrust are the main reasons for underrepresentation in research. Published research from 2022 also cited the following barriers: limited awareness of opportunities to participate in research, fears about changes in standard therapy, breaking cultural norms/stigma, religion-related concerns and mistrust of clinical research.
Focus groups found that the concerns of people who identify as Black focused more on famous past instances of abuse from scientists and healthcare professionals. Janet Brown-Friday said: “The main barrier to making clinical studies more diverse is mistrust of the medical community. We must prove, through action, that we are, indeed, worthy of trust.”
As Janet said, it is the responsibility of researchers and institutions (such as pharmaceutical companies and universities) to build trust among underrepresented groups by authentically engaging with diverse populations. Participants in focus groups have said transparency is a key method of building this trust. That means researchers being open and honest about what the aims of the research are, why it’s being done, and what is involved in taking part.
The ELSA Study, a research study co-funded by Breakthrough T1D UK, is ensuring as many children as possible in the UK aged 3-13 have the opportunity to be screened for type 1 diabetes. The researchers are achieving this by partnering with community groups including Refugee Alliance, NISHKAM Centre (a Sikh faith-based organisation) and Ileys Community Association.
In total, 14% of participants in the ELSA study are of ethnicities other than White European, which is just shy of the 18% UK population total. While there is still work for the team to do to reach the same proportion as the UK public, it shows their partnerships with minority group organisations are having a positive impact on the diversity of their research.
Here are Breakthrough T1D UK, we have a commitment to diversity, which includes our research funding.
CEO of Breakthrough T1D UK International, Aaron Kowalski, said: “We know all too well that type 1 diabetes does not discriminate — it is a disease affecting all races and ethnicities. At the same time, we recognise that within the type 1 community, inequities disproportionately affect the health and wellbeing of diverse populations.”
We know that diversity of research participants is vital for ensuring the benefits of research are accessible to all. It’s time to put those findings into practice and take proactive action to build trust and recruit diverse participants to research.
It’s a well-known issue that diverse ethnic groups are not represented in health research. But a team of medical charities and people with lived experience is driving change in this area by raising the voices of people from diverse ethnic groups through a powerful film called INVISIBLE.
This year almost 2,000 experts from around the world gathered in Lisbon, Portugal to mark the 50th anniversary of the International Society for Pediatric and Adolescent Diabetes (ISPAD). Here are five of our highlights from the conference.
The 2024 European Association for the Study of Diabetes conference was packed with inspiring presentations, expert discussions and cutting-edge research.
More than 100 years since the initial discovery, promising research is underway into newer types of insulin that work faster and are more responsive. As we face this brighter future, we take a look back at the development of insulin and the lessons we can learn from the past.
